318 research outputs found
The brain is getting ready for dinner
Every evening, as we get ready for dinner, in addition to the routine behaviors of preparing the meal itself, we also prepare our bodies to cope with the upcoming meal. This could take the form of making restaurant reservations, changing into appropriate attire, washing hands, priming ourselves with an aperitif, or even consciously avoiding snacks as the meal approaches. A study by Johnstone and colleagues in this issue of Cell Metabolism (Johnstone et al., 2006) provides evidence that in parallel to our learned preparatory behaviors, our central nervous system is going through comparable motions as it gets ready for the anticipated meal
Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats.
OBJECTIVE
Blockade of the CB1 receptor is one of the promising strategies for the treatment of obesity. Although antagonists suppress food intake and reduce body weight, the role of central versus peripheral CB1 activation on weight loss and related metabolic parameters remains to be elucidated. We therefore specifically assessed and compared the respective potential relevance of central nervous system (CNS) versus peripheral CB1 receptors in the regulation of energy homeostasis and lipid and glucose metabolism in diet-induced obese (DIO) rats.
RESEARCH DESIGN AND METHODS
Both lean and DIO rats were used for our experiments. The expression of key enzymes involved in lipid metabolism was measured by real-time PCR, and euglycemic-hyperinsulinemic clamps were used for insulin sensitivity and glucose metabolism studies.
RESULTS
Specific CNS-CB1 blockade decreased body weight and food intake but, independent of those effects, had no beneficial influence on peripheral lipid and glucose metabolism. Peripheral treatment with CB1 antagonist (Rimonabant) also reduced food intake and body weight but, in addition, independently triggered lipid mobilization pathways in white adipose tissue and cellular glucose uptake. Insulin sensitivity and skeletal muscle glucose uptake were enhanced, while hepatic glucose production was decreased during peripheral infusion of the CB1 antagonist. However, these effects depended on the antagonist-elicited reduction of food intake.
CONCLUSIONS
Several relevant metabolic processes appear to independently benefit from peripheral blockade of CB1, while CNS-CB1 blockade alone predominantly affects food intake and body weight
Ring Finger Protein 11 Inhibits Melanocortin 3 and 4 Receptor Signaling
Intact melanocortin signaling via the G protein-coupled receptors (GPCRs),
melanocortin receptor 4 (MC4R), and melanocortin receptor 3 (MC3R) is crucial
for body weight maintenance. So far, no connection between melanocortin
signaling and hypothalamic inflammation has been reported. Using a bimolecular
fluorescence complementation library screen, we identified a new interaction
partner for these receptors, ring finger protein 11 (RNF11). RNF11
participates in the constitution of the A20 complex that is involved in
reduction of tumor necrosis factor α (TNFα)-induced NFκB signaling, an
important pathway in hypothalamic inflammation. Mice treated with high-fat
diet (HFD) for 3 days demonstrated a trend toward an increase in hypothalamic
Rnf11 expression, as shown for other inflammatory markers under HFD.
Furthermore, Gs-mediated signaling of MC3/4R was demonstrated to be strongly
reduced to 20–40% by co-expression of RNF11 despite unchanged total receptor
expression. Cell surface expression was not affected for MC3R but resulted in
a significant reduction of MC4R to 61% by co-expression with RNF11. Mechanisms
linking HFD, inflammation, and metabolism remain partially understood. In this
study, a new axis between signaling of specific body weight regulating GPCRs
and factors involved in hypothalamic inflammation is suggested
Isoenergetic Feeding of Low Carbohydrate-High Fat Diets Does Not Increase Brown Adipose Tissue Thermogenic Capacity in Rats
Low-carbohydrate, high-fat (LC-HF) diets are popular for inducing weight loss in overweighed adults. Adaptive thermogenesis increased by specific effects of macronutrients on energy expenditure has been postulated to induce this weight loss. We studied brown adipose tissue (BAT) morphology and function following exposure to different LC-HF diets
A role for β-melanocyte-stimulating hormone in human body-weight regulation
SummaryPro-opiomelanocortin (POMC) expressing neurons mediate the regulation of orexigenic drive by peripheral hormones such as leptin, cholecystokinin, ghrelin, and insulin. Most research effort has focused on α-melanocyte-stimulating hormone (α-MSH) as the predominant POMC-derived neuropeptide in the central regulation of human energy balance and body weight. Here we report a missense mutation within the coding region of the POMC-derived peptide β-MSH (Y5C-β-MSH) and its association with early-onset human obesity. In vitro and in vivo data as well as postmortem human brain studies indicate that the POMC-derived neuropeptide β-MSH plays a critical role in the hypothalamic control of body weight in humans
Osteopontin Mediates Obesity-Induced Adipose Tissue Macrophage Infiltration and Insulin Resistance in Mice
Obesity is associated with a state of chronic, low-grade inflammation characterized by abnormal cytokine production and macrophage infiltration into adipose tissue, which may contribute to the development of insulin resistance. During immune responses, tissue infiltration by macrophages is dependent on the expression of osteopontin, an extracellular matrix protein and proinflammatory cytokine that promotes monocyte chemotaxis and cell motility. In the present study, we used a murine model of diet-induced obesity to examine the role of osteopontin in the accumulation of adipose tissue macrophages and the development of insulin resistance during obesity. Mice exposed to a high-fat diet exhibited increased plasma osteopontin levels, with elevated expression in macrophages recruited into adipose tissue. Obese mice lacking osteopontin displayed improved insulin sensitivity in the absence of an effect on diet-induced obesity, body composition, or energy expenditure. These mice further demonstrated decreased macrophage infiltration into adipose tissue, which may reflect both impaired macrophage motility and attenuated monocyte recruitment by stromal vascular cells. Finally, obese osteopontin-deficient mice exhibited decreased markers of inflammation, both in adipose tissue and systemically. Taken together, these results suggest that osteopontin may play a key role in linking obesity to the development of insulin resistance by promoting inflammation and the accumulation of macrophages in adipose tissue
Analysis of Human TAAR8 and Murine Taar8b Mediated Signaling Pathways and Expression Profile
The thyroid hormone derivative 3-iodothyronamine (3-T1AM) exerts metabolic
effects in vivo that contradict known effects of thyroid hormones. 3-T1AM acts
as a trace amine-associated receptor 1 (TAAR1) agonist and activates Gs
signaling in vitro. Interestingly, 3-T1AM-meditated in vivo effects persist in
Taar1 knockout-mice indicating that further targets of 3-T1AM might exist.
Here, we investigated another member of the TAAR family, the only scarcely
studied mouse and human trace-amine-associated receptor 8 (Taar8b, TAAR8). By
RT-qPCR and locked-nucleic-acid (LNA) in situ hybridization, Taar8b expression
in different mouse tissues was analyzed. Functionally, we characterized TAAR8
and Taar8b with regard to cell surface expression and signaling via different
G-protein-mediated pathways. Cell surface expression was verified by ELISA,
and cAMP accumulation was quantified by AlphaScreen for detection of Gs and/or
Gi/o signaling. Activation of G-proteins Gq/11 and G12/13 was analyzed by
reporter gene assays. Expression analyses revealed at most marginal Taar8b
expression and no gender differences for almost all analyzed tissues. In
heart, LNA-in situ hybridization demonstrated the absence of Taar8b
expression. We could not identify 3-T1AM as a ligand for TAAR8 and Taar8b, but
both receptors were characterized by a basal Gi/o signaling activity, a so far
unknown signaling pathway for TAARs
S6K1 controls pancreatic β cell size independently of intrauterine growth restriction
Type 2 diabetes mellitus (T2DM) is a worldwide heath problem that is characterized by insulin resistance and the eventual loss of β cell function. As recent studies have shown that loss of ribosomal protein (RP) S6 kinase 1 (S6K1) increases systemic insulin sensitivity, S6K1 inhibitors are being pursued as potential agents for improving insulin resistance. Here we found that S6K1 deficiency in mice also leads to decreased β cell growth, intrauterine growth restriction (IUGR), and impaired placental development. IUGR is a common complication of human pregnancy that limits the supply of oxygen and nutrients to the developing fetus, leading to diminished embryonic β cell growth and the onset of T2DM later in life. However, restoration of placental development and the rescue of IUGR by tetraploid embryo complementation did not restore β cell size or insulin levels in S6K1-/- embryos, suggesting that loss of S6K1 leads to an intrinsic β cell lesion. Consistent with this hypothesis, reexpression of S6K1 in β cells of S6K1-/- mice restored embryonic β cell size, insulin levels, glucose tolerance, and RPS6 phosphorylation, without rescuing IUGR. Together, these data suggest that a nutrient-mediated reduction in intrinsic β cell S6K1 signaling, rather than IUGR, during fetal development may underlie reduced β cell growth and eventual development of T2DM later in life
Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease
Prediction of Adipose Browning Capacity by Systematic Integration of Transcriptional Profiles
Activation and recruitment of thermogenic cells in human white adipose tissues ("browning'') can counteract obesity and associated metabolic disorders. However, quantifying the effects of therapeutic interventions on browning remains enigmatic. Here, we devise a computational tool, named ProFAT (profiling of fat tissue types), for quantifying the thermogenic potential of heterogeneous fat biopsies based on prediction of white and brown adipocyte content from raw gene expression datasets. ProFAT systematically integrates 103 mouse-fat-derived transcriptomes to identify unbiased and robust gene signatures of brown and white adipocytes. We validate ProFAT on 80 mouse and 97 human transcriptional profiles from 14 independent studies and correctly predict browning capacity upon various physiological and pharmacological stimuli. Our study represents the most exhaustive comparative analysis of public data on adipose biology toward quantification of browning after personalized medical intervention. ProFAT is freely available and should become increasingly powerful with the growing wealth of transcriptomics data
- …